Juan Eduardo Resendiz-Galvan (J E Resendiz-Galvan)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 9

Top Topics

Men Who Have Sex With Men

Pulmonary Tuberculosis

Molecular Dynamics

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy (2024)
Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Allan Kengo, Firdaus Nabeemeeah, Paolo Denti, Ryan Sabet, Gifty Okyere-Manu, Pattamukkil Abraham, Lubbe Weisner, Modiehi Helen Mosala, Sibongile Tshabalala, Janine Scholefield, Juan Eduardo Resendiz-Galvan, Neil A Martinson, Ebrahim Variava
Assessing potential drug-drug interactions between clofazimine and other frequently used agents to treat drug-resistant tuberculosis. Antimicrobial agents and chemotherapy 68 (5) (2024)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy 67 (3) (2023)
Maxwell Tawanda Chirehwa, Juan Eduardo Resendiz-Galvan, R Court, M De Kock, Lubbe Wiesner, N de Vries, J Harding, T Gumbo, R Warren, Gary Maartens, Paolo Denti, H McIlleron
Optimizing Moxifloxacin Dose in MDR-TB Participants with or without Efavirenz Coadministration Using Population Pharmacokinetic Modeling. Antimicrobial agents and chemotherapy (2023)